Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA.
about
Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MSA comprehensive review of the published assays for the quantitation of the immunosuppressant drug mycophenolic acid and its glucuronidated metabolites in biological fluids.Free mycophenolic acid determination in human plasma ultrafiltrate by a validated liquid chromatography-tandem mass spectrometry method.A critical review of microextraction by packed sorbent as a sample preparation approach in drug bioanalysis.Liquid chromatography tandem mass spectrometry in the clinical laboratory.Recent Advances in Analytical Methods for the Therapeutic Drug Monitoring of Immunosuppressive Drugs.Antineoplastic drugs and their analysis: a state of the art review.Development and Validation of Stability-indicating High Performance Liquid Chromatographic Method for the Estimation of Everolimus in Tablets.Everolimus-associated perianal ulcers in an eight-month-old heart transplant recipient.Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry.Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood.Determination of Immunosuppressive Pharmaceuticals in Whole Blood Following Kidney Transplantation by High-performance Liquid Chromatography–Tandem Mass Spectrometry
P2860
Q28083408-AAB96E38-FD77-43EF-A1E3-CF0018977F8DQ35893989-F1119781-BEBD-486E-AB68-8831541EDCA2Q36314080-FA312A74-3A93-4B17-A8C2-4B0856783919Q38112479-05E6AA72-36E8-416B-A361-46A5FE9672CEQ38260022-DCC5F7E8-7C01-4262-8F98-CB4A6F719D08Q38636104-7104CA0D-02CA-49EF-B98A-2F981667603DQ39339684-F8B25D81-A7C2-465C-BE26-662A296B6842Q42223775-4CCB5EFF-1EA7-4BBF-A305-0129EEA981BFQ48137288-04C2A281-137E-4D0B-B91D-F1806CF4CA00Q49488154-D8A47AA1-9613-4937-916F-368F1190EEA5Q51725975-BDF732CC-1ED4-430A-8BCB-1B2C64D4DE19Q58249481-D4F5B29D-C7CB-4292-9782-BA89CED2496D
P2860
Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@ast
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@en
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@nl
type
label
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@ast
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@en
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@nl
prefLabel
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@ast
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@en
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@nl
P2093
P2860
P356
P1476
Validation of an LC-MS/MS meth ...... ernal standards including MPA.
@en
P2093
Armin Buchwald
Karl Winkler
Thomas Epting
P2860
P356
10.1186/1472-6904-12-2
P577
2012-01-11T00:00:00Z